New Royal Decree Analyzed in 'Conference on Clinical Trials.'
20-09-2017
The first participant was Dr. Ángel Navarro, president and founder partner of Azierta, who presented the main changes in the New Royal Decree (RD) 1090/2015. Furthermore, he outlined a national picture of clinical research, times and efforts, both financial and human, that are necessary to put a new medication within society's reach.
Next, Dr. Antonio Portolés, director of the Foundation for Biomedical Research of the Hospital Clínico San Carlos, focused his presentation on non-commercial research promoted from public hospitals or scientific associations. In order to develop this type of studies, he mentioned the vital importance of obtaining grants from governments and supranational authorities.
The last presentation was given by Ana Isabel Terleira, Vice-president of the Ethical Committee of the Hospital de Alcorcón and clinical pharmacologist at the Hospital Clínico San Carlos, who focused on determining the implications of the New Royal Decree for CRECs (Clinical Research Ethics Committees) and how this affects the process in hospitals and several sponsors.
Source: The European University
http://biomedicasysalud.universidadeuropea.es/actualidad/la-jornada-sobre-ensayos-clinicos-analiza-el-nuevo-real-decreto
